Antrogen, Active Community... Stock Price Up 14.5%.

At this time, posts about Antrogen are rapidly increasing on portals and stock communities, while foreign investors are tentatively estimated to have net sold 11,094 shares today. Antrogen is known as a developer and seller of stem cell therapeutics.

As of 11:30 AM on the 26th, Antrogen's stock price is 60,800 KRW, up 14.5% from the previous day, with a trading volume of 2,335,292 shares, which is about 115.66% of the 5-day average trading volume. On May 21, Antrogen became a market issue with the headline "Diabetic Foot Ulcer Treatment Receives FDA Approval, Surges for Second Day."

In addition to Antrogen, posts by investors are also surging for Korea Information Certification (053300), Mason Capital (021880), and Cafe24 (042000).

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.